Prevention of Autoimmune Diabetes in Nonobese Diabetic Female Mice by Treatment with Recombinant Glutamic Acid Decarboxylase (GAD 65)

By Pleau J-M.   Fernandez-Saravia F.   Esling A.   Homo-Delarche F.   Dardenne M.  

Clinical Immunology, Vol. 76, Iss. 1, 1995-07 ,pp. : 90-95

Academic Press

Access to resources Recommend Favorite

Effects of leflunomide on experimental autoimmune myocarditis with special reference to the dendritic cells

By Dimitrijevic M.   Milenkovic M.   Milosavljevic P.   Colic M.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4149-4150

Elsevier

Access to resources Recommend Favorite

Suppression of T h 1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10

By Kawamoto S.  

International Immunology, Vol. 13, Iss. 5, 2001-05 ,pp. : 685-694

Oxford University Press

Access to resources Recommend Favorite

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

By Schmidt J.   Elflein K.   Stienekemeier M.   Rodriguez-Palmero M.   Schneider C.   Toyka K.V.   Gold R.   Hunig T.  

Journal of Neuroimmunology, Vol. 140, Iss. 1, 2003-07 ,pp. : 143-152

Elsevier

Access to resources Recommend Favorite

Differential Effect of Leflunomide on Concordant Xenogeneic Islet Graft Rejection and Recurrence of Autoimmune Diabetes

By Guo Z.   Mital D.   Shen J.   Chong A.S.F.   Tian Y.   Foster P.   Sankary H.   McChesney L.   Jensik S.C.   Williams J.W.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 463-464

Elsevier

Access to resources Recommend Favorite